Biopsy Needle Market Analysis

Product (Biopsy Needle Guns, Biopsy Needles)

Biopsy needle guns segment is poised to hold over 64.1 % biopsy needle market share by the end of 2037. Biopsy needle guns are crucial in treating patients in procedures requiring rapid, accurate, and efficient results. The features associated with biopsy guns that make the procedure more effortless are their adjustable needle depth, handheld designs, and availability in various sizes. Biopsy needle guns offer enhanced accuracy, and reduce risks and complications, with valuable outcomes for healthcare professionals, and practitioners. The demand for biopsy guns has improved efficiency in healthcare settings and has led the field toward a revolutionized and advanced approach to diagnostics.

Application (Cancer, Autoimmune Disorder, Infectious Diseases)

The cancer segment is expected to register a staggering CAGR throughout the forecast period. Breast cancer and prostate cancer are the most highlighted sub-segments of cancer applications. The diverse range of emerging cancer cases has increased the demand for biopsy needles making it a significant diagnostics tool. In July 2021, GE Healthcare installed Serena Bright, the first-contrast-guided biopsy solution in 5 leading hospitals in the U.S. to support clinicians and patients in their fight against breast cancer.

Our in-depth analysis of the biopsy needle market includes the following segments:

Product	Biopsy Needle Guns Biopsy Needles
Application	Cancer Autoimmune Disorder Infectious Diseases
End user	Hospitals Ambulatory Surgical Centers

Frequently Asked Questions (FAQ)

In the year 2024, the industry size of the biopsy needle market was over USD 1.7 billion.

The market size of the biopsy needle landscape is projected to surpass USD 3.8 billion by the end of 2037 expanding at a CAGR of 7.1% during the forecast period i.e., between 2025-2037.

The major players in the market are Becton, Medtronic Plc, Cardinal Health, Hologic Inc., Olympus Corporation, Argon Medical Devices Inc., Devicor Medical Products, Inc., Cook Group Incorporated, Boston Scientific Corporation, FUJIFILM Holdings Corporation, Dickinson and Company, and INRAD, Inc.

In terms of product, the biopsy needle guns segment is anticipated to garner the largest market share of 64.1% by 2037 and display significant growth opportunities during 2025-2037.

The market in North America is projected to hold the largest revenue share of 41.2% by the end of 2037 and provide more business opportunities in the future.

Biopsy Needle Market Analysis